AU2003202094A1 - Quinazoline compounds - Google Patents

Quinazoline compounds

Info

Publication number
AU2003202094A1
AU2003202094A1 AU2003202094A AU2003202094A AU2003202094A1 AU 2003202094 A1 AU2003202094 A1 AU 2003202094A1 AU 2003202094 A AU2003202094 A AU 2003202094A AU 2003202094 A AU2003202094 A AU 2003202094A AU 2003202094 A1 AU2003202094 A1 AU 2003202094A1
Authority
AU
Australia
Prior art keywords
quinazoline compounds
quinazoline
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2003202094A
Other versions
AU2003202094B2 (en
Inventor
Laurent Francois Andre Hennequin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP02290242 priority Critical
Priority to EP02290242.3 priority
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to PCT/GB2003/000343 priority patent/WO2003064413A1/en
Publication of AU2003202094A1 publication Critical patent/AU2003202094A1/en
Application granted granted Critical
Publication of AU2003202094B2 publication Critical patent/AU2003202094B2/en
Application status is Ceased legal-status Critical
Anticipated expiration legal-status Critical

Links

AU2003202094A 2002-02-01 2003-01-28 Quinazoline compounds Ceased AU2003202094B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP02290242 2002-02-01
EP02290242.3 2002-02-01
PCT/GB2003/000343 WO2003064413A1 (en) 2002-02-01 2003-01-28 Quinazoline compounds

Publications (2)

Publication Number Publication Date
AU2003202094A1 true AU2003202094A1 (en) 2003-09-18
AU2003202094B2 AU2003202094B2 (en) 2009-10-08

Family

ID=27635895

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003202094A Ceased AU2003202094B2 (en) 2002-02-01 2003-01-28 Quinazoline compounds

Country Status (29)

Country Link
US (3) US7268230B2 (en)
EP (2) EP1474420B1 (en)
JP (2) JP4608215B2 (en)
KR (1) KR101093345B1 (en)
CN (2) CN1625555A (en)
AR (1) AR038476A1 (en)
AT (1) AT549329T (en)
AU (1) AU2003202094B2 (en)
BR (1) BR0307151A (en)
CA (1) CA2473572C (en)
CY (1) CY1112835T1 (en)
DK (1) DK1474420T3 (en)
ES (1) ES2381781T3 (en)
HK (1) HK1070367A1 (en)
HU (1) HU0402588A3 (en)
IL (2) IL163022A (en)
IS (1) IS7362A (en)
MX (1) MXPA04007459A (en)
MY (1) MY144042A (en)
NO (1) NO328731B1 (en)
NZ (1) NZ534171A (en)
PL (1) PL371486A1 (en)
PT (1) PT1474420E (en)
RU (3) RU2365588C2 (en)
SI (1) SI1474420T1 (en)
TW (1) TWI337866B (en)
UA (1) UA81619C2 (en)
WO (1) WO2003064413A1 (en)
ZA (1) ZA200405908B (en)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9800569D0 (en) * 1998-01-12 1998-03-11 Glaxo Group Ltd Heterocyclic compounds
AT298237T (en) * 1999-02-10 2005-07-15 Astrazeneca Ab Chinazoline derivatives as angiogenesehemmer
ES2306306T3 (en) * 1999-11-05 2008-11-01 Astrazeneca Ab New derivatives of quinazolina.
CN1240688C (en) * 2000-04-07 2006-02-08 阿斯特拉曾尼卡有限公司 Quinazoline compounds
ES2264477T3 (en) * 2001-03-23 2007-01-01 Bayer Corporation Quinasa rho inhibitors.
CN1625555A (en) * 2002-02-01 2005-06-08 阿斯特拉曾尼卡有限公司 Quinazoline compounds
EP1521747B1 (en) 2002-07-15 2018-09-05 Symphony Evolution, Inc. Receptor-type kinase modulators and methods of use
PT1562955E (en) * 2002-11-04 2008-05-05 Astrazeneca Ab Quinazoline derivatives as src tyrosine kinase inhibitors
GB0316127D0 (en) * 2003-07-10 2003-08-13 Astrazeneca Ab Combination therapy
GB0318422D0 (en) 2003-08-06 2003-09-10 Astrazeneca Ab Chemical compounds
DE10340485B4 (en) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Process for the preparation of oxazolidinone-quinolone hybrids
ES2281007T3 (en) * 2003-09-19 2007-09-16 Astrazeneca Ab Derivatives of quinazolina.
GB0330002D0 (en) 2003-12-24 2004-01-28 Astrazeneca Ab Quinazoline derivatives
UA86614C2 (en) 2004-01-23 2009-05-12 Амген Инк Compound having kinase ingibitor activity, pharmaceutical composition containing thereof and use thereof for the preparation of medicine
CA2553433A1 (en) 2004-01-23 2005-08-11 Amgen Inc. Quinoline quinazoline pyridine and pyrimidine compounds and their use in the treatment of inflammation angiogenesis and cancer
NZ554017A (en) 2004-10-12 2010-06-25 Astrazeneca Ab [(Quinazolin-4-yloxy)phenyl]acetamide derivatives
US7652009B2 (en) 2004-11-30 2010-01-26 Amgem Inc. Substituted heterocycles and methods of use
JO2787B1 (en) 2005-04-27 2014-03-15 امجين إنك, Substituted Amid derivatives & methods of use
US8071768B2 (en) 2005-06-10 2011-12-06 Janssen Pharmaceutica, N.V. Alkylquinoline and alkylquinazoline kinase modulators
US7825244B2 (en) 2005-06-10 2010-11-02 Janssen Pharmaceutica Nv Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis
AR054608A1 (en) 2005-08-08 2007-06-27 Actelion Pharmaceuticals Ltd Oxazolidinone derivatives as antibacterial quinolones linked to
GB0519879D0 (en) 2005-09-30 2005-11-09 Astrazeneca Ab Chemical process
GB0523810D0 (en) * 2005-11-23 2006-01-04 Astrazeneca Ab Pharmaceutical compositions
US20090076075A1 (en) * 2006-03-02 2009-03-19 Frederic Henri Jung Quinoline derivatives
UY30183A1 (en) * 2006-03-02 2007-10-31 Astrazeneca Ab Quinoline derivatives
CL2007003158A1 (en) * 2006-11-02 2008-05-16 Astrazeneca Ab Process for preparing quinazoline derivative compounds or their pharmaceutically acceptable salts; intermediate compounds; preparation process.
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
WO2008079909A1 (en) * 2006-12-21 2008-07-03 Plexxikon, Inc. Pyrrolo [2,3-b] pyridines as kinase modulators
US7648979B2 (en) 2007-02-07 2010-01-19 Hoffmann-La Roche Inc. 5-amido-(1H-indol-2-yl)-piperazin-1-yl-methanone derivatives
US7507736B2 (en) 2007-02-07 2009-03-24 Hoffmann-La Roche Inc. Indol-2-yl-piperazin-1-yl-methanone derivatives
US20080190689A1 (en) * 2007-02-12 2008-08-14 Ballard Ebbin C Inserts for engine exhaust systems
AU2008276063B2 (en) 2007-07-17 2013-11-28 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
EP2220078B1 (en) * 2007-10-29 2013-05-22 Amgen, Inc Benzomorpholine derivatives and methods of use
ES2444128T3 (en) 2008-05-13 2014-02-24 Astrazeneca Ab New SAL-554
PL2387563T3 (en) 2009-01-16 2013-08-30 Exelixis Inc Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quinolin-4-yl]oxy}phenyl-n' - (4 -fluorophenyl) cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
CA2749926A1 (en) 2009-02-10 2010-08-19 Astrazeneca Ab Triazolo [4,3-b] pyridazine derivatives and their uses for prostate cancer
WO2010114928A2 (en) 2009-04-03 2010-10-07 F.Hoffmann-La Roche Ag Compositions and uses thereof
AU2010315126B2 (en) 2009-11-06 2015-06-25 Plexxikon, Inc. Compounds and methods for kinase modulation, and indications therefor
HUE040136T2 (en) 2011-02-07 2019-02-28 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
TWI558702B (en) 2011-02-21 2016-11-21 普雷辛肯公司 Solid forms of a pharmaceutically active substance
AR086411A1 (en) * 2011-05-20 2013-12-11 Nippon Soda Co heterocyclic nitrogen containing compound and fungicide for use in agriculture and gardening
TWI557109B (en) * 2011-12-29 2016-11-11 財團法人生物技術開發中心 Quinazoline compounds as kinase inhibitors and uses thereof
CN103288756B (en) * 2012-02-29 2016-04-20 江苏先声药物研究有限公司 Methanol solvate of a kind of quinazoline intermediate and preparation method thereof
US9242355B2 (en) 2012-04-17 2016-01-26 Black & Decker Inc. Illuminated power tool
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
WO2014127214A1 (en) 2013-02-15 2014-08-21 Kala Pharmaceuticals, Inc. Therapeutic compounds and uses thereof
CA2900680A1 (en) 2013-02-20 2014-08-28 Kala Pharmaceuticals, Inc. Therapeutic compounds and uses thereof
JP6426195B2 (en) * 2013-11-01 2018-11-21 カラ ファーマシューティカルズ インコーポレイテッド Crystalline forms of therapeutic compounds and uses thereof
US9688688B2 (en) * 2013-02-20 2017-06-27 Kala Pharmaceuticals, Inc. Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
US9890173B2 (en) 2013-11-01 2018-02-13 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
KR20160099084A (en) 2013-11-01 2016-08-19 칼라 파마슈티컬스, 인크. Crystalline forms of therapeutic compounds and uses thereof
AU2016333987A1 (en) 2015-10-05 2018-05-10 Ny State Psychiatric Institute Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies
CN105461718A (en) * 2016-01-13 2016-04-06 苏州莱安医药化学技术有限公司 5-Bromo-7-azaindole synthesis process
US10336767B2 (en) 2016-09-08 2019-07-02 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
CA3036340A1 (en) 2016-09-08 2018-03-15 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
EP3509422A1 (en) 2016-09-08 2019-07-17 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
CN107840843A (en) * 2017-10-17 2018-03-27 浙江工业大学义乌科学技术研究院有限公司 A kind of synthetic method of AZD2171 intermediate

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU174215B (en) 1976-12-15 1979-11-28 Richter Gedeon Vegyeszet Process for preparing new piperazine derivatives further acid addition and quaternary salts thereof
IL81307D0 (en) 1986-01-23 1987-08-31 Union Carbide Agricult Method for reducing moisture loss from plants and increasing crop yield utilizing nitrogen containing heterocyclic compounds and some novel polysubstituted pyridine derivatives
IL89029A (en) 1988-01-29 1993-01-31 Lilly Co Eli Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them
US5411963A (en) 1988-01-29 1995-05-02 Dowelanco Quinazoline derivatives
DE4022414A1 (en) * 1990-07-13 1992-01-16 Bayer Ag Substituted pyrrolo-pyridines
US5721237A (en) 1991-05-10 1998-02-24 Rhone-Poulenc Rorer Pharmaceuticals Inc. Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
DE69222637T2 (en) 1991-05-10 1998-02-26 Rhone Poulenc Rorer Int To mono- and bicyclic aryl and heteroaryl derivatives having an inhibitory effect on the EGF and / or PDGF receptor tyrosine kinase
US5714493A (en) 1991-05-10 1998-02-03 Rhone-Poulenc Rorer Pharmaceuticals, Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
US6645969B1 (en) 1991-05-10 2003-11-11 Aventis Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
US5710158A (en) 1991-05-10 1998-01-20 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
US5480883A (en) 1991-05-10 1996-01-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
USRE36256E (en) 1991-05-10 1999-07-20 Rhone-Poulenc Rorer Pharmaceuticals, Inc. Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
NZ243082A (en) 1991-06-28 1995-02-24 Ici Plc 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
AU661533B2 (en) 1992-01-20 1995-07-27 Astrazeneca Ab Quinazoline derivatives
FR2687402B1 (en) * 1992-02-14 1995-06-30 Lipha New azaindoles, preparation processes and medicines containing them.
US5212195A (en) * 1992-05-13 1993-05-18 Syntex (U.S.A.) Inc. Substituted indole antagonists derivatives which are angiotensin II
GB9323290D0 (en) 1992-12-10 1994-01-05 Zeneca Ltd Quinazoline derivatives
GB9314893D0 (en) 1993-07-19 1993-09-01 Zeneca Ltd Quinazoline derivatives
US5700823A (en) 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
MX9603593A (en) 1994-02-23 1997-03-29 Pfizer 4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agents.
WO1995024190A2 (en) 1994-03-07 1995-09-14 Sugen, Inc. Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
GB9505651D0 (en) 1995-03-21 1995-05-10 Agrevo Uk Ltd AgrEvo UK Limited
FR2732969B1 (en) 1995-04-14 1997-05-16 Adir New compounds pyridine their process for the preparation and pharmaceutical compositions containing them
US6046206A (en) 1995-06-07 2000-04-04 Cell Pathways, Inc. Method of treating a patient having a precancerous lesions with amide quinazoline derivatives
GB9514265D0 (en) * 1995-07-13 1995-09-13 Wellcome Found Hetrocyclic compounds
JP4009681B2 (en) 1995-11-07 2007-11-21 キリンファーマ株式会社 Quinoline derivatives and quinazoline derivatives that inhibit platelet-derived growth factor receptor autophosphorylation and pharmaceutical compositions containing them
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
TR199801530T2 (en) 1996-02-13 1998-11-23 Zeneca Limited quinazoline derivatives as VEGF inhibitors.
GB9603095D0 (en) 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
DE69709319T2 (en) 1996-03-05 2002-08-14 Astrazeneca Ab 4-anilinoquinazoline derivatives
EP0888310B1 (en) 1996-03-15 2005-09-07 AstraZeneca AB Cinnoline derivatives and use as medicine
DE19614718A1 (en) 1996-04-15 1997-10-16 Hoechst Schering Agrevo Gmbh Substituted pyridines / pyrimidines, process for their preparation, and their use as pesticides
GB9707800D0 (en) 1996-05-06 1997-06-04 Zeneca Ltd Chemical compounds
EP0907642B1 (en) 1996-06-24 2005-11-02 Pfizer Inc. Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
AT227283T (en) 1996-07-13 2002-11-15 Glaxo Group Ltd Condensed heterocyclic compounds as protein kinase inhibitors
CA2263479A1 (en) 1996-09-25 1998-04-02 Zeneca Limited Quinoline derivatives inhibiting the effect of growth factors such as vegf
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
US6225318B1 (en) 1996-10-17 2001-05-01 Pfizer Inc 4-aminoquinazolone derivatives
EP0837063A1 (en) * 1996-10-17 1998-04-22 Pfizer Inc. 4-Aminoquinazoline derivatives
JP2002501532A (en) 1997-05-30 2002-01-15 メルク エンド カンパニー インコーポレーテッド New blood vessel formation inhibitors
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
ZA9806729B (en) 1997-07-29 1999-02-02 Warner Lambert Co Irreversible inhibitors of tyrosine kinases
AT368665T (en) 1997-08-22 2007-08-15 Astrazeneca Ab Oxindolylchinazole derivatives as angiogenesehemmer
US6162804A (en) 1997-09-26 2000-12-19 Merck & Co., Inc. Tyrosine kinase inhibitors
GB9721437D0 (en) 1997-10-10 1997-12-10 Glaxo Group Ltd Heteroaromatic compounds and their use in medicine
GB9800569D0 (en) 1998-01-12 1998-03-11 Glaxo Group Ltd Heterocyclic compounds
GB9800575D0 (en) * 1998-01-12 1998-03-11 Glaxo Group Ltd Heterocyclic compounds
US6172071B1 (en) 1998-07-30 2001-01-09 Hughes Institute Lipid-lowering quinazoline derivative
US6184226B1 (en) 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
AU756556B2 (en) 1998-10-08 2003-01-16 Astrazeneca Ab Quinazoline derivatives
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB2345486A (en) 1999-01-11 2000-07-12 Glaxo Group Ltd Heteroaromatic protein tyrosine kinase inhibitors
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
AT356117T (en) 1999-01-22 2007-03-15 Kirin Brewery Derivatives of n - ((chinolinyl) oxy) -phenyl) urea and n- ((chinazolinyl) oxy) -phenyl) - urea with antitumor activity
JP3270834B2 (en) 1999-01-27 2002-04-02 ファイザー・プロダクツ・インク Useful heteroaromatic bicyclic derivatives as anticancer agents
TW519541B (en) 1999-01-27 2003-02-01 Pfizer Prod Inc Substituted bicyclic derivatives useful as anticancer agents
AT298237T (en) 1999-02-10 2005-07-15 Astrazeneca Ab Chinazoline derivatives as angiogenesehemmer
DE19911509A1 (en) 1999-03-15 2000-09-21 Boehringer Ingelheim Pharma Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation
TWI262914B (en) 1999-07-02 2006-10-01 Agouron Pharma Compounds and pharmaceutical compositions for inhibiting protein kinases
PE20010306A1 (en) 1999-07-02 2001-03-29 Agouron Pharma Indazole compounds and pharmaceutical compositions containing them useful for the inhibition of protein kinase
DE60036812T2 (en) 1999-07-07 2008-07-17 Astrazeneca Uk Ltd. Chinazoline derivatives
PT1226136E (en) 1999-10-19 2005-04-29 Merck & Co Inc Tirosin kinase inhibitors
ES2306306T3 (en) 1999-11-05 2008-11-01 Astrazeneca Ab New derivatives of quinazolina.
WO2001066099A2 (en) 2000-03-06 2001-09-13 Astrazeneca Ab Use of quinazoline derivatives as angiogenesis inhibitors
GB0008269D0 (en) 2000-04-05 2000-05-24 Astrazeneca Ab Combination chemotherapy
CN1240688C (en) 2000-04-07 2006-02-08 阿斯特拉曾尼卡有限公司 Quinazoline compounds
NZ522074A (en) 2000-05-31 2004-06-25 Astrazeneca Ab Indole derivatives with vascular damaging activity
IL152754D0 (en) 2000-06-06 2003-06-24 Astrazeneca Ab Quinazoline derivatives for the treatment of tumours
NZ522861A (en) 2000-07-07 2004-07-30 Angiogene Pharm Ltd Colchinol derivatives as vascular damaging agents
CN1255392C (en) 2000-07-07 2006-05-10 安吉奥金尼药品有限公司 Colchinol derivatives as angiogenesis inhibitors
WO2002012227A2 (en) 2000-08-09 2002-02-14 Astrazeneca Ab Indole, azaindole and indazole derivatives having vegf inhibiting activity
DE60137234D1 (en) 2000-08-09 2009-02-12 Astrazeneca Ab Cinnoline compounds
IL153947D0 (en) 2000-08-09 2003-07-31 Astrazeneca Ab Quinoline derivatives having vegf inhibiting activity
CA2419301C (en) * 2000-08-21 2009-12-08 Astrazeneca Ab Quinazoline derivatives
AU2002323406A1 (en) 2001-08-30 2003-03-18 Merck And Co., Inc. Tyrosine kinase inhibitors
WO2003037252A2 (en) 2001-10-30 2003-05-08 Merck & Co., Inc. Tyrosine kinase inhibitors
GB0126433D0 (en) 2001-11-03 2002-01-02 Astrazeneca Ab Compounds
AT423104T (en) 2001-11-03 2009-03-15 Astrazeneca Ab Quinazoline derivatives as antitumor agents
GB0126879D0 (en) 2001-11-08 2002-01-02 Astrazeneca Ab Combination therapy
CN1625555A (en) 2002-02-01 2005-06-08 阿斯特拉曾尼卡有限公司 Quinazoline compounds
EP1534287A1 (en) 2002-08-09 2005-06-01 Astrazeneca AB Combination of zd6474, an inhibitor of the vascular endothelial growth factor receptor, with radiotherapy in the treatment of cancer
GB0305142D0 (en) * 2003-03-06 2003-04-09 Eisai London Res Lab Ltd Synthesis
GB0318422D0 (en) 2003-08-06 2003-09-10 Astrazeneca Ab Chemical compounds
GB0318423D0 (en) 2003-08-06 2003-09-10 Astrazeneca Ab Chemical compounds
GB0330002D0 (en) 2003-12-24 2004-01-28 Astrazeneca Ab Quinazoline derivatives
US7117615B2 (en) 2004-05-28 2006-10-10 Nike, Inc. Shoe with reversible upper
GB0519879D0 (en) 2005-09-30 2005-11-09 Astrazeneca Ab Chemical process
CL2007003158A1 (en) 2006-11-02 2008-05-16 Astrazeneca Ab Process for preparing quinazoline derivative compounds or their pharmaceutically acceptable salts; intermediate compounds; preparation process.

Similar Documents

Publication Publication Date Title
GB0230045D0 (en) Compounds
GB0206860D0 (en) Compounds
GB0226593D0 (en) Compounds
GB0226583D0 (en) Compounds
AU2003280680A1 (en) Xanthine compound
AU2003205508A1 (en) Lamp
AU2003235759A1 (en) 4-dedimethylamino tetracycline compounds
GB0222495D0 (en) Compounds
AU2003247070A1 (en) Planar inductance
AU2003209594A1 (en) Quinazoline compounds useful in therapy
AU2003265509A1 (en) Neurostimulator
AU2002349297A1 (en) Statin-like compounds
GB0215650D0 (en) Bisarylsufonamide compounds
AU2003239909A1 (en) Enhanced-service provision
AU2002352768A1 (en) Multifunctional world-wide-walkie-talkie
SI1847539T1 (en) Quinazoline derivatives
ZA200500797B (en) Metaloxyphthalocyanine compounds
GB0212785D0 (en) Compounds
GB0215823D0 (en) Quinazoline derivatives
AU2003249738A1 (en) Ostoscope
AU2003297193A1 (en) Meta-web
AU2003273433A1 (en) Cartridge-operated coffee-machine
AU2003217234A1 (en) Modulator- amplifier
GB0221246D0 (en) Compounds
ZA200501842B (en) Dihydropyrazolopyridine compounds